世界の帯状疱疹ワクチンの市場規模は、2023年に42億5000万ドルと評価され、2024年から2030年にかけて15.3%のCAGRで成長すると予測されます。市場の成長を促す要因には、60歳以上の個人における帯状疱疹のリスクの高まりや先進国における医療政策の進展などがあります。米国疾病管理予防センター (CDC) によると、米国の3人に1人は生涯で帯状疱疹を発症する可能性があります。2021年3月、CDCはCOVID-19パンデミックの中で帯状疱疹ワクチン接種に関するガイドラインも発表し、帯状疱疹を不可欠な予防医療サービスとして認識しています。
目次
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Shingles Vaccine Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Billion)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Shingles Vaccine Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Shingles Vaccine Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Shingles Vaccine Market: Product Movement Analysis, 2023 & 2030 (USD Billion)
4.3. Shingrix
4.3.1. Shingrix Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4. Zostavax
4.4.1. Zostavax Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.5. SKYZoster
4.5.1. SKYZoster Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 5. Shingles Vaccine Market: Design Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Shingles Vaccine Market: Design Movement Analysis, 2023 & 2030 (USD Billion)
5.3. Recombinant Vaccine
5.3.1. Recombinant Vaccine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.4. Live Attenuated Vaccine
5.4.1. Live Attenuated Vaccine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 6. Shingles Vaccine Market: Regional Estimates & Trend Analysis
6.1. Shingles Vaccine Market Share, By Region, 2023 & 2030 (USD Billion)
6.2. North America
6.2.1. North America Shingles Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.2.2. U.S.
6.2.2.1. U.S. Shingles Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.2.3. Canada
6.2.3.1. Canada Shingles Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.2.4. Mexico
6.2.4.1. Mexico Shingles Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.3. Europe
6.3.1. Europe Shingles Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.3.2. UK
6.3.2.1. UK Shingles Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.3.3. Germany
6.3.3.1. Germany Shingles Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.3.4. France
6.3.4.1. France Shingles Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.3.5. Italy
6.3.5.1. Italy Shingles Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.3.6. Spain
6.3.6.1. Spain Shingles Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.3.7. Denmark
6.3.7.1. Denmark Shingles Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.3.8. Sweden
6.3.8.1. Sweden Shingles Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.3.9. Norway
6.3.9.1. Norway Shingles Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4. Asia Pacific
6.4.1. Asia Pacific Shingles Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4.2. Japan
6.4.2.1. Japan Shingles Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4.3. China
6.4.3.1. China Shingles Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4.4. India
6.4.4.1. India Shingles Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4.5. Australia
6.4.5.1. Australia Shingles Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4.6. South Korea
6.4.6.1. South Korea Shingles Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4.7. Thailand
6.4.7.1. Thailand Shingles Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.5. Latin America
6.5.1. Latin America Shingles Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.5.2. Brazil
6.5.2.1. Brazil Shingles Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.5.3. Argentina
6.5.3.1. Argentina Shingles Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.6. Middle East and Africa
6.6.1. Middle East and Africa Shingles Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.6.2. South Africa
6.6.2.1. South Africa Shingles Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.6.3. Saudi Arabia
6.6.3.1. Saudi Arabia Shingles Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.6.4. UAE
6.6.4.1. UAE Shingles Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.6.5. Kuwait
6.6.5.1. Kuwait Shingles Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. GlaxoSmithKline plc.
7.4.1.1. Participant’s Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Recent Developments/Strategic Initiatives
7.4.2. Pfizer Inc.
7.4.2.1. Participant’s Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Recent Developments/Strategic Initiatives
7.4.3. Merck & Co., Inc.
7.4.3.1. Participant’s Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Recent Developments/Strategic Initiatives
7.4.4. CanSinoBIO
7.4.4.1. Participant’s Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Recent Developments/Strategic Initiatives
7.4.5. Vaccitech
7.4.5.1. Participant’s Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Recent Developments/Strategic Initiatives
7.4.6. Green Cross Corp
7.4.6.1. Participant’s Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Recent Developments/Strategic Initiatives
7.4.7. Geneone Life Science
7.4.7.1. Participant’s Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Recent Developments/Strategic Initiatives
7.4.8. SK Bioscience
7.4.8.1. Participant’s Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Recent Developments/Strategic Initiatives
